Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Anishaa R. Patel, Dhruv N. Patel, Yaping N. Tu, Michelle Yeagley, Andrea Chobrutskiy, Boris I. Chobrutskiy & George Blanck. (2023) Chemical complementarity between immune receptor CDR3s and candidate cancer antigens correlating with reduced survival: evidence for outcome mitigation with corticosteroid treatments. Journal of Biomolecular Structure and Dynamics 41:10, pages 4632-4640.
Read now
Read now
Taha I. Huda, Moody Mihyu, Etienne C. Gozlan, Mary F. Arndt, Michael J. Diaz, Saif Zaman, Boris I. Chobrutskiy & George Blanck. (2021) Specific HLA alleles, paired with TCR V- and J-gene segment usage, link to distinct multiple myeloma survival rates. Leukemia & Lymphoma 62:7, pages 1711-1720.
Read now
Read now
Articles from other publishers (37)
Joanna J. SongAndrea ChobrutskiyBoris I. ChobrutskiyKonrad J. CiosTaha I. HudaRachel A. EakinsMichael J. Diaz & George Blanck. (2023) Chemical Complementarity of Tumor Resident, Adaptive Immune Receptor CDR3s and Previously Defined Hepatitis C Virus Epitopes Correlates with Improved Outcomes in Hepatocellular Carcinoma. Viral Immunology.
Crossref
Crossref
Peter Cheng, Konrad J. Cios, Mallika Varkhedi, Vayda R. Barker, Michelle Yeagley, Andrea Chobrutskiy, Boris I. Chobrutskiy & George Blanck. (2023) An immunoinformatics assessment of the cancer testis antigen, DDX53, as a potential early esophageal cancer antigen. Oncoscience 10, pages 59-66.
Crossref
Crossref
Dorottya B. Kacsoh, Michael J. Diaz, Etienne C. Gozlan, Arpan Sahoo, Joanna J. Song, Michelle Yeagley, Andrea Chobrutskiy, Boris I. Chobrutskiy & George Blanck. (2023) Blood-based T cell receptor anti-viral CDR3s are associated with worse overall survival for neuroblastoma. Journal of Cancer Research and Clinical Oncology 149:13, pages 12047-12056.
Crossref
Crossref
Tabitha R. Hudock, Vayda R. Barker, Brandon J. Manley, Andrea Chobrutskiy, Boris I. Chobrutskiy, Michael J. Diaz, Joanna J. Song & George Blanck. (2023) TRB CDR3-cancer testis antigen chemical complementarity scoring for identifying productive immune responses in renal cell carcinoma. Cancer Biomarkers 38:1, pages 103-110.
Crossref
Crossref
Toriana R. Dabkowski, Mallika Varkhedi, Joanna J. Song, Etienne C. Gozlan & George Blanck. (2023) Neuroblastoma and Glioblastoma Cases With Amplified Oncogenes Have Reduced Numbers of Tumor-Resident Adaptive Immune Receptor Recombinations. JCO Precision Oncology:7.
Crossref
Crossref
Deo Rei L. Agnila, Taha I. Huda, Rachel A. Eakins, Dhruv N. Patel, Monica Hsiang, Andrea Chobrutskiy, Boris I. Chobrutskiy & George Blanck. (2023) Chemical features of melanoma tumor resident TRG CDR3s associated with better survival probabilities. Melanoma Research 33:4, pages 275-282.
Crossref
Crossref
Joanna J. Song, Andrea Chobrutskiy, Boris I. Chobrutskiy, Konrad J. Cios, Taha I. Huda, Rachel A. Eakins, Michael J. Diaz & George Blanck. (2023) TRB CDR3 chemical complementarity with HBV epitopes correlates with increased hepatocellular carcinoma, disease‐free survival. Journal of Medical Virology 95:8.
Crossref
Crossref
Hope J. Wolmarans, Vayda R. Barker, Andrea Chobrutskiy, Boris I. Chobrutskiy, Taha I. Huda & George Blanck. (2023) Exploiting big data survival information to unify risk-stratification related, adaptive immune receptor parameters for multiple myeloma. Genes & Immunity 24:4, pages 194-199.
Crossref
Crossref
Shaun V. Charkowick, Taha I. Huda, Dhruv N. Patel, Michelle Yeagley, Juan F. Arturo, Konrad J. Cios, Etienne C. Gozlan, Andrea Chobrutskiy, Boris I. Chobrutskiy & George Blanck. (2023) IGL CDR3 Hydropathy and Antigen Chemical Complementarity Associated with Greater Disease-Free Survival in Lung Adenocarcinoma: Implications for Gender Disparities. Biochemical Genetics.
Crossref
Crossref
Kennedy W. Mwangi, Moses K. Kamita, Jacqueline W. Waweru, Shahin Sayed, Jonine D. Figueroa, Stefan Ambs, Konrad J. Cios, George Blanck & Francis W. Makokha. (2023) Adaptive immune receptor features related to breast cancer tissue in Kenyan patients: high immunoglobulin gene expression and high levels of gamma-delta T-cells. Breast Cancer Research and Treatment 199:1, pages 207-214.
Crossref
Crossref
Saif Zaman, Boris I. Chobrutskiy, Jessica U. Quach & George Blanck. (2023) Specific Intratumor Bacteria Genera and TRG Recombinations Associated with Greater Survival Probability in Alimentary Tract Cancers. Journal of Gastrointestinal Cancer.
Crossref
Crossref
Miguel A. Arias, Konrad J. Cios, Dorottya B. Kacsoh, Bailey E. Montgomery, Joanna J. Song, Anishaa R. Patel, Andrea Chobrutskiy, Boris I. Chobrutskiy & George Blanck. (2023) Electrostatic Complementarities of Glioblastoma-Resident T-Cell Receptors and Cancer Testis Antigens Linked to Poor Outcomes and High Levels of Sphingosine Kinase-2 Expression. Biology 12:4, pages 575.
Crossref
Crossref
George Angelakakis, Karisa S. Serraneau, Vayda R. Barker, Blake M. Callahan, Wei Lue Tong, Saif Zaman, Taha I. Huda & George Blanck. (2022) TCR gene segment usage and HLA alleles that are associated with cancer survival rates also represent racial disparities. International Journal of Immunogenetics 50:2, pages 41-47.
Crossref
Crossref
Nagehan Pakasticali, Andrea Chobrutskiy, Dhruv N. Patel, Monica Hsiang, Saif Zaman, Konrad J. Cios, George Blanck & Boris I. Chobrutskiy. (2023) Chemical Complementarity of Breast Cancer Resident, T-Cell Receptor CDR3 Domains and the Cancer Antigen, ARMC3, is Associated With Higher Levels of Survival and Granzyme Expression. Cancer Informatics 22.
Crossref
Crossref
Rachel A. Eakins, Andrea Chobrutskiy, Jamie K. Teer, Dhruv N. Patel, Monica Hsiang, Taha I. Huda, Saif Zaman, Wade J. Sexton, Domenico Coppola, Shayan Falasiri, George Blanck & Boris I. Chobrutskiy. (2022) Chemical complementarity between tumor resident, T-cell receptor CDR3s and MAGEA3/6 correlates with increased melanoma survival: Potential relevance to MAGE vaccine auto-reactivity. Molecular Immunology 150, pages 58-66.
Crossref
Crossref
Dorottya B. Kacsoh, Dhruv N. Patel, Monica Hsiang, Etienne C. Gozlan, Andrea Chobrutskiy, Boris I. Chobrutskiy & George Blanck. (2022) Tumor Resident, B-Cell Receptor Chemical Characteristics Associated with Better Overall Survival for Neuroblastoma. Journal of Molecular Neuroscience 72:9, pages 2011-2019.
Crossref
Crossref
Taha I. Huda, Michael J. Diaz, Etienne C. Gozlan, Andrea Chobrutskiy, Boris I. Chobrutskiy & George Blanck. (2022) Immunogenomics Parameters for Patient Stratification in Alzheimer’s Disease. Journal of Alzheimer's Disease 88:2, pages 619-629.
Crossref
Crossref
Brooke Mcbreairty, Boris Chobrutskiy, Andrea Chobrutskiy, Etienne Gozlan, Michael Diaz & George Blanck. (2022) Immune receptor CDR3 chemical features that preserve sequence information are highly efficient in reflecting survival distinctions: A pan‑cancer analysis. Biomedical Reports 17:2.
Crossref
Crossref
Shahid Aziz, Faisal Rasheed, Rabaab Zahra & Simone König. (2022) Gastric Cancer Pre-Stage Detection and Early Diagnosis of Gastritis Using Serum Protein Signatures. Molecules 27:9, pages 2857.
Crossref
Crossref
Boris I. Chobrutskiy, Andrea Chobrutskiy, Saif Zaman, Michelle Yeagley, Taha I. Huda & George Blanck. (2021) High-throughput, sliding-window algorithm for assessing chemical complementarity between immune receptor CDR3 domains and cancer mutant peptides: TRG-PIK3CA interactions and breast cancer. Molecular Immunology 135, pages 247-253.
Crossref
Crossref
Andrea Chobrutskiy, Boris I. Chobrutskiy, Saif Zaman, Monica Hsiang & George Blanck. (2020) Chemical features of blood-borne TRG CDR3s associated with an increased overall survival in breast cancer. Breast Cancer Research and Treatment 185:3, pages 591-600.
Crossref
Crossref
Saif ZamanBoris I. ChobrutskiyJay S. PatelAndrea DivineyYaping N. TuWei Lue TongTommy GillGeorge Blanck. (2020) Antiviral T Cell Receptor Complementarity Determining Region-3 Sequences Are Associated with a Worse Cancer Outcome: A Pancancer Analysis. Viral Immunology 33:5, pages 404-412.
Crossref
Crossref
Mary L. Disis, Lauren R. Corulli, Ekram A. Gad, Marlese R. Koehnlein, Denise L. Cecil, Peter D. Senter, Shyra J. Gardai & Nicole M. Okeley. (2020) Therapeutic and Prophylactic Antitumor Activity of an Oral Inhibitor of Fucosylation in Spontaneous Mammary Cancers. Molecular Cancer Therapeutics 19:5, pages 1102-1109.
Crossref
Crossref
Boris I. Chobrutskiy, Michelle Yeagley, Andrea Diviney, Saif Zaman, Etienne C. Gozlan, Price Tipping, Darush M. Koohestani, Andrea M. Roca & George Blanck. (2020) A scoring system for the electrostatic complementarities of T‐cell receptors and cancer‐mutant amino acids: multi‐cancer analyses of associated survival rates. Immunology 159:4, pages 373-383.
Crossref
Crossref
Michael J. Diaz, Boris I. Chobrutskiy, Saif Zaman & George Blanck. (2020) Immunogenomics of colorectal adenocarcinoma: Survival distinctions represented by immune receptor, CDR3 chemical features and high expression of BTN gene family members. Cancer Treatment and Research Communications 24, pages 100196.
Crossref
Crossref
Nagehan Pakasticali, Tommy Gill, Boris I. Chobrutskiy, Wei Lue Tong, Michael Ramsamooj & George Blanck. (2019) TRAV gene segments further away from the TRAJ gene segment cluster appear more commonly in human tumor and blood samples. Molecular Immunology 116, pages 174-179.
Crossref
Crossref
Andrea M. Roca, Boris I. Chobrutskiy, Blake M. Callahan & George Blanck. (2019) T-cell receptor V and J usage paired with specific HLA alleles associates with distinct cervical cancer survival rates. Human Immunology 80:4, pages 237-242.
Crossref
Crossref
Huan-Ming Hsu, Chi-Ming Chu, Yu-Jia Chang, Jyh-Cherng Yu, Chien-Ting Chen, Chen-En Jian, Chia-Yi Lee, Yueh-Tao Chiang, Chi-Wen Chang & Yu-Tien Chang. (2019) Six novel immunoglobulin genes as biomarkers for better prognosis in triple-negative breast cancer by gene co-expression network analysis. Scientific Reports 9:1.
Crossref
Crossref
Boris I. Chobrutskiy, Saif Zaman, Andrea Diviney, Moody M. Mihyu & George Blanck. (2018) T-cell receptor-α CDR3 domain chemical features correlate with survival rates in bladder cancer. Journal of Cancer Research and Clinical Oncology 145:3, pages 615-623.
Crossref
Crossref
Kendall R. Clark, Wei Lue Tong, Blake M. Callahan, John M. Yavorski, Yaping N. Tu & George Blanck. (2018) TRB‐J1 usage, in combination with the HLA‐A*01:01 allele, represents an apparent survival advantage for uterine corpus endometrial carcinoma: Comparisons with microscopic assessments of lymphocyte infiltrates. International Journal of Immunogenetics 46:1, pages 31-37.
Crossref
Crossref
Wei Lue Tong, Blake M. Callahan, Yaping N. Tu, Saif Zaman, Boris I. Chobrutskiy & George Blanck. (2018) Immune receptor recombinations from breast cancer exome files, independently and in combination with specific HLA alleles, correlate with better survival rates. Breast Cancer Research and Treatment 173:1, pages 167-177.
Crossref
Crossref
Saif Zaman, Boris I. Chobrutskiy, Jay S. Patel, Blake M. Callahan, Wei Lue Tong & George Blanck. (2018) Mutant cytoskeletal and ECM peptides sensitive to the ST14 protease are associated with a worse outcome for glioblastoma multiforme. Biochemical and Biophysical Research Communications 503:4, pages 2218-2225.
Crossref
Crossref
Jacob C. Kinskey, Yaping N. Tu, Wei Lue Tong, John M. Yavorski & George Blanck. (2018) Recovery of Immunoglobulin VJ Recombinations from Pancreatic Cancer Exome Files Strongly Correlates with Reduced Survival. Cancer Microenvironment 11:1, pages 51-59.
Crossref
Crossref
Yaping N. Tu, Wei Lue Tong, John M. Yavorski & George Blanck. (2018) Immunogenomics: A Negative Prostate Cancer Outcome Associated with TcR-γ/δ Recombinations. Cancer Microenvironment 11:1, pages 41-49.
Crossref
Crossref
Blake M. Callahan, John M. Yavorski, Yaping N. Tu, Wei Lue Tong, Jacob C. Kinskey, Kendall R. Clark, Timothy J. Fawcett & George Blanck. (2018) T-cell receptor-β V and J usage, in combination with particular HLA class I and class II alleles, correlates with cancer survival patterns. Cancer Immunology, Immunotherapy 67:6, pages 885-892.
Crossref
Crossref
Blake M. Callahan, Wei Lue Tong & George Blanck. (2018) T cell receptor-β J usage, in combination with particular HLA class II alleles, correlates with better cancer survival rates. Immunologic Research 66:2, pages 219-223.
Crossref
Crossref
Yaping N Tu, Wei Lue Tong, Timothy J Fawcett & George Blanck. (2017) Lung tumor exome files with T-cell receptor recombinations: a mouse model of T-cell infiltrates reflecting mutation burdens. Laboratory Investigation 97:12, pages 1516-1520.
Crossref
Crossref